Molecular modeling suggests that ARBs may have potent anti-inflammatory properties by modulating VDR, PPARgamma, and CCR2b receptors, warranting further experimental validation.
No takes yet. Share an insight, caveat, or question.
Molecular predictions of ARB receptor effects should not alter prescribing; they leave open experimental validation of anti-inflammatory potential.
Marshall et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: